Nov 19, 2019
Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference
Nov 08, 2019
Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
Oct 16, 2019
Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Oct 08, 2019
Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Sep 04, 2019
Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
Aug 14, 2019
Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
Aug 08, 2019
Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jun 24, 2019
Sutro Biopharma Appoints Biopharma Veteran Connie Matsui as Board Chair
Jun 18, 2019
Sutro Biopharma to Present at the JMP Securities Life Sciences Conference
May 16, 2019
Sutro Biopharma Announces Presentation at the 2019 European Hematology Association Congress
Jan 29, 2019
Sutro Biopharma Expands Leadership Team with Appointment of Vice President of Chemistry
Dec 19, 2018
Sutro Achieves $10 Million Milestone Payment from Celgene
Nov 14, 2018
Sutro Biopharma Reports Third Quarter 2018 Financial Results
Nov 13, 2018
Sutro Announces IND Submission and Conclusion of 30-Day Review Period for STRO-002, an Antibody-Drug Conjugate (ADC) Targeting Anti-Folate Receptor-a for Treatment of Ovarian and Endometrial Cancer
Sep 26, 2018
Sutro Biopharma Announces $85.0 Million Initial Public Offering
Sep 12, 2018
Sutro Taps Worsley as Chief Business Officer; Names Fitzpatrick as People and Communications Chief
Aug 13, 2018
Sutro and The Leukemia & Lymphoma Society Partner on Lymphoma and Multiple Myeloma Treatment